Verrica Pharmaceuticals Inc (VRCA)

$4.69 +0.02 (0.43%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	44.11M
Revenue (ttm)	7.57M
Net Income (ttm)	-76.58M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,011.62%
Debt to Equity Ratio	-2.13

Volume	58,500
Avg Vol	217,492
Day's Range	N/A - N/A
Shares Out	9.45M
Stochastic %K	92%
Beta	1.71
Analysts	Sell
Price Target	$15.00

Company Profile

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and sale of medications for the treatment of skin diseases in the United States. The company's product pipeline includes YCANTH (VP-102), which is in phase III clinical trial for the treatment of common warts; and has completed phase II clinical trial for treating external genital warts, as well as for molluscum contagiosum. It also develops VP-315, an oncolytic peptide-based injectable therapy that is i...

Industry: Biotechnology

Sector: Healthcare

Phone: 484 453 3300

Website: www.verrica.com

Address:

44 West Gay Street, Suite 400, West Chester, United States

nUme22 Oct. 6 at 6:44 PM

$SPRB Okay, I was WRONG...lol.. understatement of the year $VRCA next..

0 · Reply

Thespartantrades Oct. 6 at 5:16 PM

$VRCA $IMNN $PC $CNSP Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve.

0 · Reply

Abouelyazeed Oct. 5 at 2:29 PM

$VRCA Insiders

0 · Reply

Vikingsstrade Oct. 3 at 5:54 PM

Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve! $FOXO $CHPT $AGRI $VRCA

0 · Reply